-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
2015 is a year when classified procurement is really trying to advance
.
2016 is a year for medical institutions to give full play to their procurement entities
Looking back on the past five years, volume procurement has changed from hanging in the air and priceless, until now it has taken root and combined volume and price.
It can be said that the pace of centralized drug procurement is steadily steadily moving and becoming more and more practical
.
In 2021, looking back on the past 8 months, and then looking forward to the days to come, volume purchases are undoubtedly spreading from point to surface
.
The medical insurance, which integrates pricing power, procurement power, and payment power, continues to exert its strength.
Purchasing catalog: 500 varieties are still instructive for purchasing in quantity
Purchasing catalog: 500 varieties are still instructive for purchasing in quantity The 500 catalog in 2020 has still been used as the basis for the country and provinces to purchase in volume
.
Including the Hubei Special Procurement of Chinese Patent Medicines and the Guangdong Inter-provincial Procurement Alliance, the selection of varieties is basically unmatched
The author emphasizes again: 500 varieties are not fixed and unchanged
.
The relevant central points in 2021 will be centered on 500 varieties, spread rapidly, and directly radiate to all varieties currently in clinical use
Variety selection: the use of medicines in key areas seamlessly hits the volume procurement
Variety selection: the use of medicines in key areas seamlessly hits the volume procurement At the product level, systemic anti-infective drugs, digestive system and metabolic drugs, cardiovascular drugs, nervous system and anti-tumor drugs have become the focus of national and local procurement
.
As the large varieties are successively adopted by the state and the province, the remaining mature varieties will be purchased in quantities that are at most two to three years
Procurement method: classified procurement is solidly implemented,
Procurement method: classified procurement is solidly implemented, It can be seen that the original centralized drug procurement pilot projects carried out at the local level, especially the mass procurement pilot at the city level, will increasingly focus on the provincial level
.
At the municipal level, it is less and less likely to carry out mass procurement alone
It is worth noting that, in the context of clinical pathways and disease-based payment, medical front-line resource utilization control will be stricter, and the hospital will take the initiative to participate in cost control while paying attention to the exact curative effect
.
It can be seen from the national volume procurement and provincial-level projects over the years that the thinking of the centralized drug procurement organization is gradually changing from low prices to ensuring supply at reasonable prices, especially when the price of chemical medicines is increased to a certain level.
Written at the end: Basic medicines may change the bureau or stir up the volume procurement market
Written at the end: Basic medicines may change the bureau or stir up the volume procurement market Not surprisingly, in 2021, the national essential medicine adjustment will be officially launched and the results will be announced.
According to rumors, the national essential medicine catalog will be officially released in the second half of the year
.
The proprietary Chinese medicines that enter the country's basic medicines are basically varieties with clear functions and indications, complete clinical reports, practical and safe efficacy, and convenient dosage forms
In a word, under the new situation, volume purchase is access! Volume purchase tests a price decision-making ability, and even more tests a company’s strategic decision-making ability, that is: the cognitive ability to evaluate the consistency of generic drugs + the company’s perception of generic drugs Consistent development direction decision-making ability + product screening decision-making ability
.
In the past, the extensive price decision-making system must take market leaders as the starting point.
The state and local governments should carry out mass procurement.
For enterprises, they must also establish a sense of mass bidding: how much stock there is in the market and how much increment there will be in the future.
It is a measure of whether a market will do or not, and whether to bid or not
.